title: [Assessment of risk to neuro-psychomotor development: screening using the Test Denver II and identification of maternal risks].
abstract: OBJECTIVE
  To identify a positive screening test for developmental delay in children by the Denver Test II and their risk factors.
  
  
  METHODS
  A sample of 398 children was studied at 0 the 12 months of age regarding their neurodevelopment. The Denver II Test was used. The children who failed in two or more items of the test were suspected of having neurodevelopment delay. A set of independent variables was: socioeconomic, reproductive and environmental, birth conditions children's care. Analyses were performed using chi-square test and multivariate techinique logistic regression.
  
  
  RESULTS
  At of 0 - 12 months of age, 45,73% (182) of the total of 398 children failed in the screening test. After adjusting for possible confounding variables, failure was associated with family lower income children, gestacional age less than 38 weeks, socioeconomic status family, schooling of the mother, mother's age, use of drug.
  
  
  CONCLUSIONS
  This study demonstrates: 1--The Denver Test permited screening the delays development; 2--Maternal risk factors may interfere in the child's neurodevelopmental.
authors.affiliation: PPGCSA-UFRN.
authors.forename: Hilton Luiz
authors.initials: HL
authors.lastname: da Cunha
authors.forename: Aurea Nogueira
authors.initials: AN
authors.lastname: de Melo
mesh_terms: D000328:Adult; D001938:Brazil; D002657:Child Development / Q000187:drug effects / Q000502:physiology*; D002658:Developmental Disabilities / Q000175:diagnosis*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008403:Mass Screening; D008423:Maternal Age; D008425:Maternal Behavior / Q000502:physiology*; D008875:Middle Aged; D009483:Neuropsychological Tests; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology*; D012307:Risk Factors; D017678:Sex Distribution; D012959:Socioeconomic Factors; D019966:Substance-Related Disorders / Q000150:complications